Cue Biopharma, Inc. (CUE)

SEC filing

Cue Biopharma, Inc.

CUE · CIK 1645460

4 · Oct 14, 2026 · VP, Prin. Accounting Officer Meluzio Michael Vincent sold 1,144 shares at $28.05/share ($32,089)

VP, Prin. Accounting Officer Meluzio Michael Vincent sold 1,144 shares at $28.05/share ($32,089)

xslF345X06/form4-10152026_011010.xml

xslF345X06/form4-10152026_011010.xmlSEC.gov

Graphics and non-inline formats (not embedded below).